Abstract
Purpose: To characterize a highly pathogenic avian influenza (HPAI) H5N8 for engineering recombinant 6-+ 2 vaccine strain based on reverse genetic technology.
Methods: A total of 135 swab samples from various birds were collected from different parts of Saudi Arabia as part of an influenza surveillance activity. The samples were checked for influenza virus infection using reverse transcriptase-polymerase chain reaction (RT-PCR). Furthermore, Avian influenza H5N8 (Nchicken/KSA/1-NRC/2018), was used for the generation of H5N8 vaccine strain. The vaccine was tested on specific pathogen-free (SPF) chicken purchased from a local market.
Results: The results indicate that the candidate vaccine (rgH5N8/KSA) induced specific neutralizing antibodies in chicken, and thereby protected the chickens from subsequent infections of H5N8.
Conclusion: The study reinforces the development of a vaccine against avian influenza H5N8 virus isolated in Saudi Arabia, suggesting its possible application against the influenza virus associated with bird flu